Report: Do the Emerging Treatments for Celiac Disease Offer Significant Improvements over the Gluten-Free Diet?


September 1, 2011
SKU: DECR6554510
License type:
Table of Contents Related Reports
House Dust Mite Allergy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
House Dust Mite Allergy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'House Dust Mite Allergy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic  |  read more...
$2,000.00
Oropharyngeal Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Oropharyngeal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oropharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer,  |  read more...
$2,000.00
Pulmonary Tuberculosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Pulmonary Tuberculosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Tuberculosis,  |  read more...
$2,000.00
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Muscle Atrophy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Muscle Atrophy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Atrophy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Muscle Atrophy,  |  read more...
$2,000.00
Metastatic Ovarian Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Influenza B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Influenza B Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Influenza B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic  |  read more...
$2,000.00
Primary Systemic Amyloidosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Primary Systemic Amyloidosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Vitiligo – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Vitiligo – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Vitiligo - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vitiligo, complete with latest  |  read more...
$2,000.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Drug Discovery Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!